So what was his argument, again? I don't know how good his argument is about the location of drug development (one must consider the differing
regulatory environments as well. I don't know what it is like in other countries, but the FDA makes drug development extraordinarily expensive). However, one point that should be obvious is that the drug market in the U.S. is attractive and ...